- Home
- ESP vs CUE Comparison
ESP vs CUE Comparison
Compare ESP & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- CUE
- Stock Information
- Founded
- ESP 1928
- CUE 2014
- Country
- ESP United States
- CUE United States
- Employees
- ESP N/A
- CUE N/A
- Industry
- ESP Industrial Machinery/Components
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- CUE Health Care
- Exchange
- ESP Nasdaq
- CUE Nasdaq
- Market Cap
- ESP 148.8M
- CUE 59.5M
- IPO Year
- ESP N/A
- CUE 2018
- Fundamental
- Price
- ESP $45.94
- CUE $0.73
- Analyst Decision
- ESP
- CUE Strong Buy
- Analyst Count
- ESP 0
- CUE 2
- Target Price
- ESP N/A
- CUE $3.00
- AVG Volume (30 Days)
- ESP 31.9K
- CUE 132.0K
- Earning Date
- ESP 09-16-2025
- CUE 11-13-2025
- Dividend Yield
- ESP 2.22%
- CUE N/A
- EPS Growth
- ESP 31.88
- CUE N/A
- EPS
- ESP 3.02
- CUE N/A
- Revenue
- ESP $43,950,872.00
- CUE $8,286,000.00
- Revenue This Year
- ESP N/A
- CUE N/A
- Revenue Next Year
- ESP N/A
- CUE $13.27
- P/E Ratio
- ESP $17.12
- CUE N/A
- Revenue Growth
- ESP 13.46
- CUE N/A
- 52 Week Low
- ESP $22.50
- CUE $0.45
- 52 Week High
- ESP $55.00
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- ESP 44.66
- CUE 37.04
- Support Level
- ESP $43.10
- CUE $0.71
- Resistance Level
- ESP $55.00
- CUE $0.78
- Average True Range (ATR)
- ESP 2.45
- CUE 0.03
- MACD
- ESP -0.23
- CUE -0.01
- Stochastic Oscillator
- ESP 23.85
- CUE 18.90
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.